This company has been marked as potentially delisted and may not be actively trading. Obalon Therapeutics (OBLN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock OBLN vs. ICAD, GUTS, MGRM, MBOT, SRTS, NVNO, CTSO, NSPR, INO, and APYXShould you be buying Obalon Therapeutics stock or one of its competitors? The main competitors of Obalon Therapeutics include iCAD (ICAD), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), Microbot Medical (MBOT), Sensus Healthcare (SRTS), enVVeno Medical (NVNO), Cytosorbents (CTSO), InspireMD (NSPR), Inovio Pharmaceuticals (INO), and Apyx Medical (APYX). Obalon Therapeutics vs. Its Competitors iCAD Fractyl Health Monogram Orthopaedics Microbot Medical Sensus Healthcare enVVeno Medical Cytosorbents InspireMD Inovio Pharmaceuticals Apyx Medical icad (NASDAQ:ICAD) and Obalon Therapeutics (NASDAQ:OBLN) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations, community ranking and profitability. Is ICAD or OBLN more profitable? icad has a net margin of -26.63% compared to Obalon Therapeutics' net margin of -776.76%. icad's return on equity of -15.03% beat Obalon Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets icad-26.63% -15.03% -11.77% Obalon Therapeutics -776.76%-161.38%-83.58% Does the media favor ICAD or OBLN? In the previous week, icad had 4 more articles in the media than Obalon Therapeutics. MarketBeat recorded 4 mentions for icad and 0 mentions for Obalon Therapeutics. icad's average media sentiment score of 0.95 beat Obalon Therapeutics' score of 0.00 indicating that icad is being referred to more favorably in the media. Company Overall Sentiment icad Positive Obalon Therapeutics Neutral Do institutionals and insiders believe in ICAD or OBLN? 24.6% of icad shares are held by institutional investors. Comparatively, 18.6% of Obalon Therapeutics shares are held by institutional investors. 10.3% of icad shares are held by insiders. Comparatively, 8.1% of Obalon Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts rate ICAD or OBLN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score icad 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Obalon Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer ICAD or OBLN? Obalon Therapeutics received 18 more outperform votes than icad when rated by MarketBeat users. However, 59.84% of users gave icad an outperform vote while only 46.42% of users gave Obalon Therapeutics an outperform vote. CompanyUnderperformOutperformicadOutperform Votes22859.84% Underperform Votes15340.16% Obalon TherapeuticsOutperform Votes24646.42% Underperform Votes28453.58% Which has more risk & volatility, ICAD or OBLN? icad has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Obalon Therapeutics has a beta of -1.23, suggesting that its stock price is 223% less volatile than the S&P 500. Which has stronger valuation & earnings, ICAD or OBLN? icad has higher revenue and earnings than Obalon Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioicad$19.61M5.17-$5.62M-$0.19-19.42Obalon Therapeutics$1.59M16.07-$12.33MN/AN/A Summaryicad beats Obalon Therapeutics on 12 of the 15 factors compared between the two stocks. Get Obalon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OBLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBLN vs. The Competition Export to ExcelMetricObalon TherapeuticsSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.56M$239.32M$5.21B$8.59BDividend YieldN/AN/A5.38%4.20%P/E Ratio-1.895.4125.6219.15Price / Sales16.0771.05396.59101.14Price / CashN/A196.1235.5255.99Price / Book4.2510.487.975.79Net Income-$12.33M-$26.39M$3.15B$248.80M Obalon Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBLNObalon TherapeuticsN/A$2.55-0.4%N/A+1,202.8%$25.56M$1.59M-1.892ICADiCAD0.9867 of 5 stars$3.83+4.1%N/A+154.5%$105.21M$19.53M-29.46140Positive NewsShort Interest ↓GUTSFractyl Health2.3329 of 5 stars$2.09+1.5%$11.00+426.3%-60.1%$100.89M$60K-0.17102News CoveragePositive NewsGap UpMGRMMonogram Orthopaedics2.3751 of 5 stars$2.80+5.3%$5.40+92.9%+31.3%$99.93M$365.00K-5.9628MBOTMicrobot Medical2.1577 of 5 stars$2.45+4.7%$9.00+267.3%+136.3%$89.13MN/A-3.0620SRTSSensus Healthcare1.4693 of 5 stars$4.82+0.2%$11.67+142.0%-8.9%$79.27M$39.49M12.0540NVNOenVVeno Medical0.1166 of 5 stars$4.41+1.6%N/A-13.3%$77.33MN/A-3.4219Gap UpCTSOCytosorbents1.2828 of 5 stars$1.22+11.9%$5.50+350.8%+49.2%$76.38M$35.33M-3.39220NSPRInspireMD2.7088 of 5 stars$2.45+5.6%$4.50+83.7%-2.4%$75.06M$7.03M-3.2750INOInovio Pharmaceuticals3.5485 of 5 stars$2.00flat$9.75+387.5%-75.7%$73.35M$283.10K-0.63320News CoverageAPYXApyx Medical2.7152 of 5 stars$1.86+6.3%N/A+50.4%$70.30M$47.29M-2.24270Positive NewsShort Interest ↓Gap Up Related Companies and Tools Related Companies ICAD Competitors GUTS Competitors MGRM Competitors MBOT Competitors SRTS Competitors NVNO Competitors CTSO Competitors NSPR Competitors INO Competitors APYX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OBLN) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Obalon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Obalon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OBLN Stock Free OBLN Stock Alerts